Design, synthesis, and anti-triple negative breast cancer activity of novel Toosendanin derivatives-Reference-Cited by-同舟云学术

Design, synthesis, and anti-triple negative breast cancer activity of novel Toosendanin derivatives

Published:2023-03 Issue: Volume:83 Page:129187
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Zhang Honglin,Chen Yiyan,Liu Qiuyu,Xiao Wen-Wen,Shao Li-Dong^ORCID,Pan Zheng-Hong^ORCID,Chen Chuan-Huizi,Li Dashan

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference24 articles.

1. Cancer Statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. Racial disparity and triple-negative breast cancer in African-American women: A multifaceted affair between obesity, biology, and socioeconomic determinants;Siddharth;Cancers,2018

4. Triple-negative breast cancer comparison with canine mammary tumors from light microscopy to molecular pathology;Namagerdi;Front Oncol,2020

5. Triple-negative breast cancer molecular subtyping and treatment progress;Yin;Breast Cancer Res,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of acetophenone/piperazin-2-one hybrids as selective anti-TNBC cancer agents by causing DNA damage;Bioorganic & Medicinal Chemistry Letters;2024-08

2. Biomimetic Total Synthesis of Bimagnolignan: A Natural Anti-Breast Cancer Agent;Organic Letters;2024-03-14